This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berul, C. I. Search for Related Content PubMed PubMed Citation Articles by Berul, C. I. Pubmed/NCBI databases Medline Plus Health Information Cardiac Arrest Related Collections Electrocardiology Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2008;117:2178-2180.)
© 2008 American Heart Association, Inc.

Editorial

Congenital Long-QT Syndromes

Who’s at Risk for Sudden Cardiac Death?

Charles I. Berul, MD

From the Department of Cardiology, Children’s Hospital Boston, and Department of Pediatrics, Harvard Medical School, Boston, Mass.

Correspondence to Charles I. Berul, MD, Senior Associate in Cardiology, Children’s Hospital Boston, 300 Longwood Ave, Boston, MA 02115. E-mail charles.berul@cardio.chboston.org

Key Words: Editorials • arrhythmia • genetics • pediatrics • risk factors • death, sudden • long-QT syndrome

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The congenital long-QT syndromes (LQTS) were initially described approximately 50 years ago.^1–3 The principal events are syncope, seizures, and ventricular tachycardia, characteristically torsade de pointes. Most often, this arrhythmia is self terminating, producing a syncopal episode; however, LQTS is responsible for a significant proportion of sudden cardiac deaths (SCDs) in young people without structural heart disease, estimated to have an incidence of approximately 1 in 2500 and causing thousands of deaths annually.^4–6 Characteristic ECG signs of LQTS include QT-interval prolongation and T-wave abnormalities. The heart rate–corrected QT interval (QTc) can range from 370 to >700 ms, clearly overlapping that of normal individuals, and a single ECG may not manifest the stereotypical features.^7–9 Some patients have a normal or borderline QTc at rest but prolongation with exertion or β-adrenergic stimulation. Provocative testing with exercise or catecholamine infusion may improve the sensitivity of LQTS clinical detection.^9–11 The inciting triggers are somewhat mutation-specific. Patients with potassium channel mutations typically have episodes during physical or emotional stress, whereas those with sodium channel defects have more events with bradycardia and during sleep.^12–15 Symptoms, including syncope or SCD, can manifest anytime from the neonatal period to adulthood. Because risk stratification is still being refined, it is often recommended that most LQTS patients be treated with β-adrenergic blocking medications, but a diagnostic challenge is deciding who needs more specific or aggressive therapies. Interventions for LQTS include implantation of a permanent pacemaker or implantable cardioverter defibrillator (ICD), as well as consideration of left cardiac sympathetic denervation. If interventional . . . [Full Text of this Article]

This article has been cited by other articles:

				A. M. Goldman, E. Glasscock, J. Yoo, T. T. Chen, T. L. Klassen, and J. L. Noebels Arrhythmia in Heart and Brain: KCNQ1 Mutations Link Epilepsy and Sudden Unexplained Death Science Translational Medicine, October 14, 2009; 1(2): 2ra6 - 2ra6. [Abstract] [Full Text] [PDF]